SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-008769
Filing Date
2018-04-23
Accepted
2018-04-23 17:23:00
Documents
11
Period of Report
2018-04-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PROJECT EAGLE CLOSING 8-K prtk-8k_20180423.htm 8-K 57404
2 EX-1.1 prtk-ex11_8.htm EX-1.1 253438
3 EX-4.1 prtk-ex41_7.htm EX-4.1 778017
4 EX-4.3 prtk-ex43_6.htm EX-4.3 33609
5 GRAPHIC g2018042320593510417220.jpg GRAPHIC 3174
6 GRAPHIC g2018042320593391317216.jpg GRAPHIC 2540
7 GRAPHIC g2018042320593447717218.jpg GRAPHIC 2674
8 GRAPHIC g2018042320593639220799.jpg GRAPHIC 4634
9 GRAPHIC g2018042320593423217217.jpg GRAPHIC 2448
10 GRAPHIC g2018042320593485217219.jpg GRAPHIC 2177
11 GRAPHIC g2018042320593369017215.jpg GRAPHIC 2066
  Complete submission text file 0001564590-18-008769.txt   1152338
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36066 | Film No.: 18769575
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1